ARTG 481247Monalisa Lidocaine Dermal Filler - Hard Type - Dermal tissue reconstructive material, microbe-derived
ARTG ID: 481247 · Jvaf Pty Ltd · Genoss Co Ltd · Class III · Started February 28, 2025
Good Name: Jvaf Pty Ltd - Monalisa Lidocaine Dermal Filler - Hard Type - Dermal tissue reconstructive material, microbe-derived
- Risk Class
- Class III
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 481247
- Start Date
- February 28, 2025
- Effective Date
- February 28, 2025
- Name
- Jvaf Pty Ltd
- Name
- Genoss Co Ltd
- Country
- South Korea
- Address
- 1F Gyeonggi R&DB Centre / 226 2F GSBC 105 Gwanggyo-ro Yeongtong-gu, Suwon-si, Gyeonggi-do
Monalisa Lidocaine Dermal Filler - Hard Type is indicated for mid-to-deep dermal implantation for the correction of moderate to severe facial wrinkles and folds and contain the local anaesthetic lidocaine for a more comfortable injection in patient over the age 21. It is a sterile injectable 1mL pre-filled syringes containing hyaluronic acid and lidocaine gel.
Access comprehensive regulatory information for Monalisa Lidocaine Dermal Filler - Hard Type - Dermal tissue reconstructive material, microbe-derived in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 481247 and sponsored by Jvaf Pty Ltd, manufactured by Genoss Co Ltd in South Korea. The device registration started on February 28, 2025.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.